Note 3 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
9 Months Ended |
|---|---|
|
Mar. 31, 2019
USD ($)
| |
| Beginning balance | $ 597,890 |
| Acquisitions (Note 4) | 123,648 |
| Currency translation | (1,930) |
| Ending balance | 719,608 |
| Protein Sciences [Member] | |
| Beginning balance | 347,918 |
| Acquisitions (Note 4) | 13,582 |
| Currency translation | (1,821) |
| Ending balance | 359,679 |
| Diagnostics and Genomics [Member] | |
| Beginning balance | 249,972 |
| Acquisitions (Note 4) | 110,066 |
| Currency translation | (108) |
| Ending balance | $ 359,929 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|